The mTOR pathway is dysregulated in various cancers including cholangiocarcinoma (Chung et al., 2009; Ma and Blenis, 2009), making mTOR an important target for the development of new anticancer drugs (Faivre et al., 2006). The gene discussed is MTOR; the disease is cancer.